CD4 and myeloid sarcoma: Utilising these metrics, we performed an exploratory analysis of public clonotypes which may be relevant to MS pathogenesis, focusing on public CD4+CD45RO+ clones within HLA DRB1*15:01 positive patients as we hypothesised this would provide the greatest likelihood of defining pathogenic clones.